Maria Singer - Universal Health Independent Director
| UHS Stock | USD 178.70 0.62 0.35% |
Director
Maria Singer is Independent Director of Universal Health Services since 2020.
| Age | 46 |
| Tenure | 5 years |
| Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
| Phone | 610 768 3300 |
| Web | https://uhs.com |
Maria Singer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Maria Singer against Universal Health stock is an integral part of due diligence when investing in Universal Health. Maria Singer insider activity provides valuable insight into whether Universal Health is net buyers or sellers over its current business cycle. Note, Universal Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Universal Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Maria Singer over a week ago Disposition of 5000 shares by Maria Singer of Universal Health at 67.69 subject to Rule 16b-3 | ||
Maria Singer over three months ago Acquisition by Maria Singer of 1097 shares of Universal Health subject to Rule 16b-3 |
Universal Health Management Efficiency
The company has Return on Asset of 0.0741 % which means that on every $100 spent on assets, it made $0.0741 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1794 %, implying that it generated $0.1794 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2025. Return On Capital Employed is likely to drop to 0.10 in 2025. At this time, Universal Health's Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 1.28 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Charles Elson | Encompass Health Corp | 60 | |
| Yvonne Curl | Encompass Health Corp | 65 | |
| Barbara Desoer | DaVita HealthCare Partners | 67 | |
| Daphne Jones | AMN Healthcare Services | 64 | |
| Meg Crofton | HCA Holdings | 67 | |
| Pascal Desroches | DaVita HealthCare Partners | 55 | |
| Charles Berg | DaVita HealthCare Partners | 63 | |
| Elizabeth Hirsch | Community Health Systems | 67 | |
| Ross Comeaux | Community Health Systems | N/A | |
| Cecil Haney | Tenet Healthcare | 65 | |
| Russell Carson | Select Medical Holdings | 77 | |
| Daniel Thomas | Select Medical Holdings | 62 | |
| Katherine Davisson | Select Medical Holdings | 53 | |
| Phyllis Yale | DaVita HealthCare Partners | 62 | |
| John Maupin | Encompass Health Corp | 73 | |
| Robert Dennis | HCA Holdings | 67 | |
| Marilyn Tavenner | Select Medical Holdings | 69 | |
| Brooke Matthews | Lifestance Health Group | N/A | |
| Leslye Katz | Encompass Health Corp | 66 | |
| Thomas Scully | Select Medical Holdings | 63 | |
| Christopher Reidy | Encompass Health Corp | 64 | |
Management Performance
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0741 |
Universal Health Services Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lynda Smirz, Chief VP | ||
| Elliot Sussman, Independent Director | ||
| Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
| Lawrence Gibbs, Independent Director | ||
| Geraldine Geckle, Senior Resources | ||
| Warren Nimetz, Director | ||
| Victor Radina, Senior Development | ||
| Marvin Pember, Executive Vice President, President of Acute Care Division | ||
| Eileen McDonnell, Lead Independent Director | ||
| Alan Miller, Executive Chairman, CEO, Member of Executive Committee and Member of Fin. Committee | ||
| Michael Nelson, Senior Services | ||
| Maria Singer, Independent Director | ||
| Marc Miller, President, Director and Member of Fin. Committee | ||
| Matthew Klein, Senior Counsel | ||
| Jim Clark, Senior Division | ||
| Edward Sim, Executive Division | ||
| Thomas Day, Senior Division | ||
| Maria Zangardi, Senior Officer | ||
| Steve Filton, Chief Financial Officer, Executive Vice President, Secretary |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0741 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 16.29 B | ||||
| Shares Outstanding | 57.75 M | ||||
| Shares Owned By Insiders | 4.71 % | ||||
| Shares Owned By Institutions | 96.30 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | 13.68 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.